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Tension-pore formationThe inﬂuences of ergosterol and cholesterol on the activity of the nystatin were investigated experimentally in a
POPCmodelmembrane aswell as theoretically. The behavior of giant unilamellar vesicles (GUVs) under osmotic
stress due to the formation of transmembrane poreswas observed on single vesicles at different nystatin concen-
trations using phase-contrast microscopy. A signiﬁcant shift of the typical vesicle behavior, i.e., morphological al-
terations, membrane bursts, slow vesicle ruptures and explosions, towards lower nystatin concentrations was
detected in the ergosterol-containing vesicles and a slight shift towards higher nystatin concentrations was de-
tected in the cholesterol-containing membranes. In addition, the nystatin activity was shown to be signiﬁcantly
affected by the ergosterol membrane’s molar fraction in a non-proportional manner. The observed tension-pore
behavior was interpreted using a theoretical model based on the osmotic phenomena induced by the occurrence
of size-selective nystatin pores. The number of nystatin pores for different vesicle behavior was theoretically de-
termined and the role of the different mechanical characteristics of the membrane, i.e., the membrane's expan-
sivity and bending moduli, the line tension and the lysis tension, in the tension-pore formation process was
quantiﬁed. The sterol-induced changes could not be explained adequately on the basis of the different mechan-
ical characteristics, and were therefore interpreted mainly by the direct inﬂuences of the membrane sterols on
the membrane binding, the partition and the pore-formation process of nystatin.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Nystatin is an antimicotic agent that belongs to polyene macrolid
antibiotics, a family of compounds characterized by a large lactone
ring with three to eight conjugated double bonds. It has a broad
spectrum of activity against fungi, but it is mainly used for the topical
treatment of mucosal and cutaneous Candida infections due to its
toxic effects when administered systemically [1,2]. As a pore-forming
agent, nystatin could also be capable of translocating different cargo
molecules into the cells, which makes it a potential speciﬁc drug-
delivery agent. The biological activity of the polyenes seems to result
from their ability to form barrel-like, membrane-spanning channels in
the plasma membrane of antibiotic-sensitive organisms [3–5]. These
transmembrane pores have size-selective properties: in the case of
nystatin they are only permeable to solutes no larger than glucose [6].
The increase in the plasma-membrane permeability to ions andulty of Medicine, University of
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.small molecules causes a disturbance to the cellular electrochemical
gradients, which ultimately leads to cell lysis and death [3].
Like many cellular membrane activities [7–9] the polyene mode of
action has been shown to be affected by the sterol composition in the
membrane [10–12]. These effects are probably associated with the
sterol-induced changes in the membrane's structural and dynamic
properties, such as the regularity of the membrane's lipid organization,
the membrane's free volume and the motility of the membrane's
constituents [8–12]. Several studies have reported the tendency of
cholesterol to increase the line tension and the membrane-expansivity
modulus of lipid membranes [13–19]. The addition of ergosterol
into the membranes also results in an increase of the membrane-
expansivity modulus and the vesicle lysis tension; however, these
membrane-stabilizing effects are smaller than those of cholesterol
[20–22]. Additionally, various conceptual models were designed to ex-
plain the nature of the sterol-lipid membrane interactions [23–25].
The superlattice models suggest distributions with local maxima at
theoretically predictable sterol critical molar fractions [26–28].
A signiﬁcant impact of sterols on the nystatin mode of action has
been shown by studies undertaken, in particular, with cholesterol-
and ergosterol-containingmembranes [29–31]. Many differentmolecu-
lar mechanisms describing the role of sterols in the pore-formation
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antibiotic-sterol complexes [32,33] and the inﬂuences on the polyene
membrane's partition due to the sterol-induced changes in the
membrane's lipid organization [34,35]. The studies revealed that the
increased regularity of the membrane's lipid organization by the addi-
tion of cholesterol inhibits the partition of polyenes into the membrane
[11–13]. Ergosterol has an even more pronounced lipid-ordering effect
than cholesterol in the bilayers formed with saturated lipids [36–39];
however, these effects are substantially diminished in the case of the
membranes consisting of an unsaturated lipid like POPC [39]. This is in
accordance with the facilitating inﬂuences of ergosterol on the nystatin
activity in POPC membranes [40]. Furthermore, it has been shown that
nystatin has a tendency to form intra-membrane complexeswith ergos-
terol, which could be a major contributing factor to the increase in the
nystatin pore-forming activity [32,33]. The changed ﬂuorescence
lifetimes of nystatin indicate the formation of nystatin-nystatin or
nystatin-sterol complexes [41]. In addition, it has also been found that
polyenes are able to form pores in membranes that do not contain any
sterols [29,42,43]. The number of nystatin molecules forming the
transmembrane pore is estimated to be between 4 and 12 [5,44], and
the measured effective radii are mostly in the range between 0.4 and
0.5 nm [45,46]. The radius of nystatin pores was not found to be
inﬂuenced by the addition of cholesterol or ergosterol into the
membrane [47].
Further theoretical and experimental studies are needed to elucidate
the polyene-membrane interaction and to obtain a more precise and
comprehensive understanding of the inﬂuences of the variations in
the membrane's sterol content. Our recent work with sterol-free giant
unilamellar vesicles (GUVs) and nystatin has revealed some distinct
vesicle behavior patterns [43] that could not be obtained from studies
on the bulk properties of the membrane-nystatin interactions for
small and large unilamellar vesicles [5,30,31]. The GUVs were chosen
because they can be manipulated and observed individually, using a
micropipettemanipulation technique and a phase-contrast microscopy.
Hence,we also apply our approach in thepresent study, inwhichwe ob-
serve the inﬂuences of membrane sterols (with a focus on ergosterol
and its molar fraction) on the nystatin membrane activity and establish
a comparison of the behavior of sterol-free and sterol-containing GUVs.
We relate the experimental results to the predictions of the theoretical
model based on the osmotic phenomena induced by the occurrence of
size-selective nystatin pores. Our primary concern is an understanding
of the observed differences in the vesicle behavior in connection with
the effects of sterols on the membrane's mechanical properties as
well as on the formation of nystatin pores. We discuss the results in
the context of the tension-pore formation process and the ﬁndings in
the literature.2. Materials and methods
2.1. Preparation of vesicles (GUVs) and nystatin solutions
The GUVs were prepared from POPC and/or POPC-sterol mixtures
according to themodiﬁedmethod of Angelova et al. [48]. The ergosterol
(Sigma-Aldrich, USA) was added to the POPC (Avanti Polar Lipids, USA)
in molar fractions of 15, 30 or 45% and the cholesterol (Avanti Polar
Lipids, USA) in a 45% molar fraction. The POPC and/or the POPC-sterol
mixtures were dissolved in a 1:1 chloroform-methanol solution, spread
over platinum electrodes and vacuum dried. Afterwards, the electrodes
were placed in an electroformation chamber ﬁlledwith 2ml of 0.2-mol/l
sucrose solution. An AC electric ﬁeld was applied, which was stepwise
reduced from a starting value of 1 V/mm and 10 Hz to a ﬁnal value of
0.1 V/mmand 1 Hz. The formed vesicles containing the sucrose solution
were transferred in an isomolar glucose solution and kept there at room
temperature. The samples were used within three days of preparation;
however, the sterol-containing vesicles were not used earlier than twodays after their preparation in order to enable a sufﬁcient level of sterol
lateral distribution in the membranes.
A stock suspension of 10 mmol/l nystatin was prepared from the
lyophilized nystatin (Fluka, Sigma, USA). Pure methanol was used as
a solvent, since nystatin has poor water solubility. It was stored in a
dark place at−4 °C. The nystatin solutions with the desired concen-
trations were prepared immediately prior to the experiment. A stock
suspension of the appropriate volume was diluted with a 0.2-mol/l
glucose solution and stirred using a vortex. The methanol was main-
tained at volume fractions under 10% in order to minimize its effects
on the phospholipid membrane; the methanol volume fraction only
increased by 1% as the nystatin concentration was increased by
100 μmol/l. It should be noted, as an experimental limitation, that
the saturation effects of nystatin in the surrounding solution associ-
ated with its poor water solubility were detected at nystatin concen-
trations higher than 600 μmol/l.2.2. Experimental set-up and procedure
The GUVs were observed with an inverted microscope (IMT-2,
Olympus, Japan; objective LWD CDPlan40X, NA = 0.55) using phase-
contrast microscopy. The images were continuously acquired with a
chilled black-and-white CCD camera (C5985, Hamamatsu, Japan) and
stored in a personal computer. The images of the vesicles were kept
focused in the equatorial plane during the experimental procedure.
A two-compartment cell was used for the vesicle manipulation [43].
The ﬁrst compartment was ﬁlled with the glucose solution that
contained the vesicles. The vesicles with an appropriate size and with
no anomalies were selected and transferred into the second, measuring
compartment using a micropipette manipulation system. The measur-
ing compartment was ﬁlled with nystatin solutions of the desired con-
centrations. The glucose concentrations were equal to 0.2 mol/l in
both the compartments. The nystatin concentration remained practical-
ly constant during the transfer due to the much smaller volume of the
transferred solution compared to the volume of the measuring com-
partment. The measurements were performed at a room temperature
of 24 ± 1 °C.
Individual unilamellar, nearly spherical vesicles with diameters of
40 ± 20 μm were chosen and transferred in groups of 1–5 vesicles
into the measuring compartment with nystatin concentrations of be-
tween 10 and 800 μmol/l. The vesicles were observed within the ﬁrst
60min after their transfer, depending on the duration of the investigat-
ed process. At the beginning of each measuring sequence, the control
experiments were performed in an isomolar glucose solution without
nystatin in order to test the stability of the prepared GUVs and the inﬂu-
ence of the micromanipulation procedure. In addition, the GUVs were
exposed to a methanol-glucose solution without nystatin in order to
check the inﬂuence of methanol. The methanol volume fraction was
6% that is our maximal methanol concentration used in experiments
with nystatin.2.3. Image analysis
The images were evaluated qualitatively and quantitatively [43].
Qualitatively, the characteristic vesicle behavior patterns were deter-
mined at different nystatin concentrations based on a continuous obser-
vation of the phase-contrast images. Quantitatively, the images were
assessed in terms of the brightness proﬁle along the line across the
vesicle membrane in a radial direction, which was ﬁtted in the halo
region by a Gaussian curve [49]. The halo intensity was determined at
discrete time intervals and used as a measure of the changing sucrose-
glucose ratio inside the vesicle. All the images were analyzed using
in-house-produced software, while the quantitative results were
evaluated using standard statistical procedures.
Fig. 2. Three characteristic responses of sterol-free and sterol-containing GUVs at low
nystatin concentrations (up to 100 μmol/l). Insigniﬁcant fading of the GUVs without
sterols (□, n = 9) and the GUVs containing 45 mol% cholesterol (○, n = 16) at a
100-μmol/l nystatin concentration. Signiﬁcant (partial) fading of the GUVs containing
30 mol% ergosterol at 25 μmol/l (▼, n = 7), 50 μmol/l (■, n = 10) and 75 μmol/l
(●, n = 8) nystatin concentration. Slow ruptures of GUVs containing 30 mol% ergosterol
at a 100-μmol/l nystatin concentration (n = 8) with an average survival time equal to
1930 s are depicted by a vertical arrow. No signiﬁcant fading of sterol-free GUVs was
observed in a control, 6% methanol concentration without nystatin (∇, n = 9). The
halo-intensity values are normalized with respect to the initial halo-intensity value of
the individual vesicles; vertical bars represent standard deviations.
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3.1. Characteristic behavior of the GUVs at low nystatin concentrations
At low nystatin concentrations, i.e., at concentrations below approx-
imately 100 μmol/l, no signiﬁcant changes in the sterol-free vesicle
behavior compared to the control experimentswere detected [43]. Sim-
ilarly, the cholesterol-containing GUVs demonstrated no signiﬁcant
morphological alterations or any halo-intensity decrease over the
whole measuring period of one hour in this nystatin concentration
range (Figs. 1a and 2). Furthermore, the transfer of vesicles into
glucose-methanol solution without nystatin did not cause any signiﬁ-
cant vesicle fading in sterol-free (Fig. 2) and sterol-containing GUVs.
In contrast, the ergosterol-containing GUVs demonstrated various
shape transformations as well as different osmotic phenomena follow-
ing a short, post-transfer incubation period of a few minutes. At the
lowest measured nystatin concentrations (around 10 μmol/l) diverse
membrane formations were observed, whereas the halo intensity
of the GUVs was not reduced signiﬁcantly. The shapes and sizes of
membrane formations were quite diverse, ranging from ﬁlamentous
protrusions to necklace-shaped rows or groups of spheres. The most
commonly observed formations were external protrusions, slowly
growing over time. The described formations were similar to those
observed in cholesterol-containing vesicles at signiﬁcantly higher
concentrations (Fig. 1b).
However, the effects of ergosterolmolar fraction became apparent at
nystatin concentrations equal to or greater than 25 μmol/l. The vesicles
containing 30 mol% of ergosterol experienced a slow and partial fading
at 25-, 50- and 75-μmol/l nystatin concentrations (Fig. 2). Their halo
intensities decreased to 69%, 61% and 57% of the initial values in the
measuring period of one hour with an average halo-intensity decrease
rate equal to (1.05± 0.15) ×10−4 s−1. The slow ruptures of the vesicles
were detected at a minimum nystatin concentration of 100 μmol/l forFig. 1.Characteristic behavior patterns of 45-mol% cholesterol-containing vesicles: a) Nor-
mal behavior of the GUVs at a nystatin concentration of 100 μmol/l. The snapshots were
taken in 10-minute intervals. b) The occurrence of variousmembrane formations at a nys-
tatin concentration of 200 μmol/l. The arrows indicate the beginning and the end of the
protrusion, gradually evolving from predominantly thin tethers to spherically shaped
necklaces. Note the absence of these structures on the ﬁrst image. The snapshots were
taken at 6, 17, 21, 25 and 29 min after the transfer into the nystatin solution. c) An almost
complete loss of halo intensity as a consequence of many transient membrane bursts at
300 μmol/l nystatin concentration. The snapshots were taken at 1, 6, 27.5, 39.5 and 48 min
after the transfer into the nystatin solution. The scale bars indicate a length of 20 μm.this ergosterol fraction (Fig. 2). The term slow rupture denotes a large
membrane opening, lasting up to several seconds, which is accompa-
nied by a substantial leak of the vesicle content and results in a signiﬁ-
cant loss of its halo intensity (Fig. 3a; see also Appendix B). The
membrane reseals afterwards. This cycle of membrane opening and
resealing is repeated several times. More seldom, a stable opening
with a distinctive oriﬁce is observed around which an amorphous relict
of the vesicle is formed [43]. At the end, the vesicle disintegrates into
amorphous lipid debris (Fig. 3a). On the other hand, the nystatin effects
were much more intense at 15 and 45 ergosterol mol% – slow ruptures
of the vesicles were observed already for a 25-μmol/l nystatin concen-
tration. Survival times, deﬁned as the times from the vesicle transfer
into the nystatin solution to the beginning of the vesicle rupture, were
1363 s and 712 s for the vesicles containing 15 and 45 mol% ergosterol
at a 25-μmol/l nystatin concentration. These survival times were signif-
icantly shorter than the survival times of the vesicles containing
30 mol% of ergosterol at a 100-μmol/l nystatin concentration, the aver-
age value of which was 1932 s (Fig. 2).
Thus, the observations show that a change in the ergosterol molar
fraction of 15 mol% induced a dramatic change in the vesicle response
at a 25-μmol/l nystatin concentration. Namely, an ergosterol contentFig. 3. Different types of vesicle ruptures (see also text and Appendix B for more detailed
descriptions): a) A typical slow rupture of the vesicle. The snapshots were taken approx.
21 min after the transfer of the 30-mol% ergosterol-containing vesicle into the
200-μmol/l nystatin solution. The duration of the slow rupture was approximately
2 s. b) A typical fast rupture (explosion) of the vesicle. The ﬁrst snapshot was taken
approx. 4.5 min after the transfer of the 45-mol% ergosterol-containing vesicle into a
500-μmol/l nystatin solution. The next consecutive snapshots were taken 0.07, 0.2, 0.33
and 0.5 s after the ﬁrst one. The scale bars indicate a length of 20 μm.
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change in the characteristic vesicle behavior from membrane bursts to
slow ruptures (Fig. 2).
3.2. Characteristic behavior of GUVs at intermediate nystatin concentrations
The behavior of sterol-free vesicles in an intermediate nystatin
concentration range, i.e., between 100 and 400 μmol/l, was character-
ized in terms of various membrane formations for the lower region of
these concentrations and an almost complete loss of halo intensity as
a consequence ofmany transientmembrane bursts for the higher region
of these concentrations. Slow ruptures of the vesicles were only charac-
teristic for nystatin concentrations around 400 μmol/l. On the other
hand, the behavior patterns of the sterol-containing vesicles were
found to be, as already seen for the low nystatin concentration range,
strongly dependent on the membrane's sterol composition.
Vesicle membrane formations and fading were observed in the
experiments with 45 mol% cholesterol-containing vesicles in this
nystatin concentration range. Their fading was slow and partial at a
200-μmol/l nystatin concentration, and it was often accompanied by
membrane formations of different shapes (Fig. 1b). Substantially higher
rates of halo-intensity decrease and almost complete losses of halo
intensity, without shape changes, were measured after approximately
45 and 25 min for 300- and 400-μmol/l nystatin concentrations (Fig. 4,
Table 1). A series of transient membrane bursts connected with the
loss of vesicle content could be observed (Fig. 1c). During each burst,
the vesicle membrane opens transiently and a minor fraction of the
vesicle content is extruded out of the vesicle. The cycle of membrane
opening and resealing is repeated without the destruction of the
vesicle [43].
A comparison with the sterol-free vesicles depicts a comparable
fading for 200-μmol/l nystatin; however, the effect of the addition
of cholesterol into the membrane could clearly be seen at 300- and
400-μmol/l nystatin concentrations (Fig. 4, Table 1). Signiﬁcantly lower
halo-intensity decrease rates were found in the cholesterol-containing
GUVs. Note that this rate was lower even for the 100-μmol/l higher
nystatin concentration in cholesterol-containing vesicles, i.e., at
400 μmol/l, if compared to the sterol-free GUVs at the 300-μmol/l
nystatin concentration (Fig. 4, Table 1). The inﬂuence of cholesterolFig. 4. Typical responses of sterol-free and sterol-containingGUVs at intermediate nystatin
concentrations. Partial fading of the GUVs without sterols (□, n = 7) and the GUVs
containing 45 mol% cholesterol (○, n = 11) at 200 μmol/l. Almost total fading of the
GUVs without sterols (■, n = 8) and the GUVs containing 45 mol% cholesterol at
300 μmol/l (●, n = 10) and at 400 μmol/l (*, n = 8). The average survival time of the
slow ruptures of GUVs containing 30 mol% ergosterol at a 200-μmol/l nystatin concentra-
tion (n=9) is depicted by a vertical arrow. The halo-intensity values are normalizedwith
respect to the initial halo-intensity value of the individual vesicles; vertical bars represent
standard deviations.content becomes even clearer if the characteristic behavior pattern
of the cholesterol-containing vesicles and the sterol-free ones are
compared at the same, 400-μmol/l nystatin concentration. It should
be pointed out that the cholesterol-containing vesicles are still in
the regime of transient bursts, while the sterol-free ones already
experience slow ruptures at this nystatin concentration.
In contrast, the ergosterol-containing GUVs already demonstrated
slow and fast ruptures over the entire intermediate nystatin concentra-
tion range (Fig. 4). As their name implies, fast ruptures or explosions
indicate a more sudden event than slow ruptures. Typically, a quick
disintegration of the entire vesicle is observed, often proceeded by a
discrete bulge at the site of the breaking membrane (Fig. 3b; see also
Appendix B). During the explosion, the vesicle membrane suddenly
opens and the vesicle, which seemed intact just a fraction of a second
ago, simply disappears, leaving almost no visible traces behind. The
average vesicle survival times differed signiﬁcantly with respect to
the membrane's ergosterol content. They were the shortest for the
45 mol% and the longest for the 30 mol% ergosterol-containing
GUVs with their values equal to 386 s and 1114 s for the 200-μmol/l
nystatin concentration, while the average survival time for the
15-mol%-containing GUVs was in the middle, with its value of
approximately 650 s.3.3. Characteristic behavior of GUVs at high nystatin concentrations:
the dependence of vesicle ruptures on the membrane composition and
nystatin concentration
At nystatin concentrations higher than 400 μmol/l, vesicle ruptures
were observed to substitute for the fading process of the vesicles,
which took place due to the membrane bursts (transient pores), also
in the cholesterol-containing and sterol-free membranes. The concen-
tration threshold for the appearance of vesicle ruptures was found to
be at 500 μmol/l for the 45-mol% cholesterol-containing GUVs and at a
400-μmol/l nystatin concentration for the sterol-free GUVs, both of
which are substantially higher than the ergosterol-containing GUVs
(Figs. 4 and 5). To recall, the 30-mol% ergosterol-containing GUVs
demonstrated a tendency to rupture even at 100 μmol/l, while the
15- and 45-mol% ergosterol-containing GUVs started to rupture at
nystatin concentrations even as low as 25 μmol/l (Figs. 2, 4 and 5).
The fractions of slow ruptures at different nystatin concentrations
and vesicle compositions are shown in Fig. 5. The incidence of slow
ruptures was found to decrease with increasing nystatin concentrations
for all the measured vesicle compositions. Slow ruptures were the pre-
dominant type of vesicle ruptures for concentrations up to 500 μmol/l;
moreover, fast ruptures (explosions) were very rarely encountered at
nystatin concentrations below 100 μmol/l. In addition, slow ruptures
were more frequently observed for the 30-mol% ergosterol-containing
GUVs than for the 15- and 45-mol% ergosterol-containing GUVs in the
nystatin concentration range between 100 and 500 μmol/l (Fig. 5).
However, a signiﬁcant shift towards the explosions occurred at nystatin
concentrations around 550 μmol/l, and this type of rupture became the
predominant one (Fig. 5). A shift between these two types of ruptures
occurred in a relatively narrow concentration range of approximately
100 μmol/l for all the vesicle compositions. However, it appeared to
be much less abrupt and less signiﬁcant for the cholesterol- and
ergosterol-containing GUVs in comparison to that observed for the
sterol-free ones. The nystatin concentration span characterized by the
predominance of slow ruptures was the widest for the ergosterol-
containing GUVs (from less than 100 to approximately 500 μmol/l),
narrower for the sterol-free GUVs (from 400 to 500 μmol/l) and the
narrowest for the cholesterol-containing GUVs (only approximately
500 μmol/l) (Fig. 5). In addition, in the ergosterol-containing GUVs the
concentration span was dependent on the ergosterol's molar fraction,
i.e., larger values were found for the 15- and 45-mol% ergosterol-
containing GUVs than for the 30-mol% ones.
Table 1
Dependence of the major characteristics of the fading process on the cholesterol
content for the intermediate nystatin concentration range. The decrease rates of the
fastest-fading phase and the ﬁnal halo intensities are listed.
Cholesterol
content [%]
Nystatin concentration
[μmol/l]
Rate of halo intensity
decrease [10−4 s−1]
Final halo intensity
[% of initial]
45 200 −0.7 76
0 200 −0.8 71
45 300 −3 13
45 400 −5 8
0 300 −13 12
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4.1. Basic overview
A theoretical model describing the characteristic patterns of vesicle
behavior was developed. It is assumed that the observed behavior can
be regarded as a consequence of an osmotic stress in the vesicles after
the formation of the nystatin-induced transmembrane pores with a
ﬁxed diameter [43,49–51]. The transmembrane permeability, induced
by these pores is size-discriminating [45] and, consequently, glucose
molecules with a smaller effective radius experience a higher
membrane permeability than the sucrose molecules [52]. Hence,
the osmolarity of the solution inside the vesicle, which is initially
equal to that of the glucose solution outside the vesicle, gradually
increases after the formation of the nystatin pores. Consequently,
an inﬂux of water molecules into the vesicle is established, resulting
in an increased volume of the vesicle, which induces an increased
membrane tension and a corresponding hydrostatic pressure [49,51].
The phospholipid membrane water permeability is namely several
orders of magnitude higher than the permeability of large sugar mole-
cules [52,53]. This leads to a characteristic time for the water content
and the osmotic pressure changes of approximately 0.2 s in a vesicle
with a radius of 20 μm.On the other hand, the corresponding character-
istic time for glucose molecules is approximately 2000 h.
In the next subsections the ﬂow of water and sugar molecules
through the nystatin transmembrane pores, and additionally, the ﬂow
of water directly through the intact phospholipid membrane, will be
described. As a consequence of these ﬂows, the increase in the vesicle
volume and the membrane tension, followed by the incidence of a
tension pore, will be presented in more detail.Fig. 5. Relationship between the relative fraction of slow ruptures with respect to the sum
of slow ruptures and explosions, and the nystatin concentration at different vesicle
compositions: sterol-free GUVs (Δ), and sterol-containing GUVs: 15 mol% (▲), 30 mol%
(●), 45 mol% (■) ergosterol and 45 mol% cholesterol (○). The number of vesicles
measured at each nystatin concentrationwas from7 to 16 (11.3± 2.2). The lines between
the measured points are drawn only to guide the eye.4.2. Vesicle behavior before the formation of the tension pore
4.2.1. Flow through the nystatin pores
Both contributions of the volume ﬂow, i.e., the ﬂow ofwater, have to
be considered: the ﬂow directly through the phospholipid bilayer as
well as the ﬂow through the nystatin pores. In contrast, in the case of
the solutes, i.e., sugar molecules, only the ﬂow through the nystatin
pores is relevant. In the model it was assumed that their number
and radius do not change with time. The volume ﬂow (JNP) and the
ﬂow of the sugar molecules (ΦNP,i) through the nystatin pores
depend on the difference in the hydrostatic pressures inside and
outside the vesicle (Δp), and on the differences in the sugar number
densities between the inner and outer solutions (Δci) [54], where i
refers to glucose (G) or sucrose (S) molecules. The corresponding
equations can be written as
JNP ¼−Lp Δp−kBT∑iσ iΔcið Þ ð1Þ
for the volume ﬂow, and
ΦNP;i ¼ 1−σ ið Þci JNP−PikBTΔci ð2Þ
for the solute ﬂow. The ﬂows are taken to be positive when the
volume of the vesicle increases and the number of sugar molecules
in the vesicle increases. Lp is the hydraulic permeability for the pores,
kB is the Boltzmann constant, T is the absolute temperature, σi and ci
are the reﬂection coefﬁcients and the mean solute concentrations, and
Pi are the sugar permeabilities.
The sugar permeabilities (Pi) depend on the diffusion constant of
each sugar molecule (Di), the number and the radius of the peptide
pores (NP and RNP), and the membrane thickness (d). If the nystatin
pores are assumed to have a cylindrical shape and are equal in size,
the permeabilities Pi can be described by the equation [55]:
Pi ¼ Di
NpπR
2
NP
d
 1− Ri
RNP
 2
 1−2:104 Ri
RNP
þ 2:09 Ri
RNP
 3
−0:95 Ri
RNP
 5 
;
ð3Þ
with Ri being equal to the effective radii of the sugar molecules
(RS and RG). It is clear that the membrane permeabilities depend
on the ratio between Ri and RNP.
4.2.2. Volume ﬂow through the phospholipid bilayer
The volume ﬂow through the phospholipid bilayer can be expressed
in a similar way with the equation
JPB ¼−AlPBðΔp−kBT
X
i
ΔciÞ; ð4Þ
where A is the membrane area and lPB is the permeability coefﬁcient of
the phospholipid bilayer with respect to water.
4.2.3. Determination of the vesicle's volume and membrane tension
The volume of the vesicle is therefore determined by the sum
of JNP and JPB [Eqs. (1) and (4)], which depend on the osmotic
conditions, hence
dV
dt
¼ JNP þ JPB: ð5Þ
The osmotic pressure difference is given by the equation
Δπ ¼ kBT
NG
V
−cG þ
Ns
V
−cS
 
; ð6Þ
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in the vesicle with volume V, and cG and cS are the number densities of
both sugars outside the vesicle. The latter two are taken to be constant,
since the volume outside the vesicle is much larger than the vesicle
volume, whereas the number of sugar molecules in the vesicle can be
calculated using Eq. (2).
If the inﬂow of glucose molecules is larger than the outﬂow of
sucrosemolecules (the positive change inNG is larger than the negative
one in NS), which is the case in our experiments, the volume of the
vesicle and its membrane area increase. This affects the lateral tension
(λ) in the vesicle membrane and, consequently, the hydrostatic
pressure that can be expressed by the Laplace equation
Δp ¼ 2λ
Rv
; ð7Þ
with Rv being the radius of the vesicle. The lateral tension in the
membrane (λ) equals kA(A− A0)/A0, where kA is the membrane's ex-
pansivity modulus and A0 is the membrane's equilibrium area.
4.3. Vesicle behavior after the formation of the tension pore
4.3.1. Incidence of the tension pore and the ﬂow through it
When the membrane area reaches its critical value, corresponding
to the critical membrane tension (λc) of the lipid bilayers [20,56,57],
a tension pore occurs. The membrane area is decreased by the area of
the tension pore if we assume that the radius of the vesicle remains
constant during the formation of the tension pore. Themechanical ener-
gy of the vesicle (W) is determined by the sum of the membrane's
stretching energy and the energy of the rim of the tension pore [50].
Taking into account themembrane undulations [58], the corresponding
sum of the energy terms can be written in the form
W ¼ kA
2A0
4πR2v−AL þ ΔA 1−
AL
4πR2v
 
−A0
 2
þ Γ  2πrTP ; ð8Þ
where rTP is the radius of the tension pore with the area equal to AL ¼ 2
πRv Rv−
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
R2v−r2TP
q 
, and Γ is the line tension.ΔA is the total excess area
due to the membrane undulations, that can be estimated by
ΔA ¼ A0
kBT
8πkc
ln
Rv=dð Þ2 þ λR2v=kc
1þ λR2v=kc
; ð9Þ
with kc the membrane bending constant [58] (Table 2).
The radius of the tension pore is determined by the minimum ofW;
therefore, at equilibrium the tension-pore radius as a function of kA and
Γ is determined by ∂W/∂rTP = 0. The pressure in the vesicle is larger
than the pressure in the surroundings since the area of the membrane
(A) is slightly larger than A0 due to the membrane tension caused by
the line tension. The membrane tension (λ) is calculated from the areaTable 2
Critical number of nystatin pores (NP) during the transition from type-II to type-III
tension-pore behavior for the POPC membrane without sterols and with the addition of
30 mol% ergosterol or 30 mol% cholesterol. They are calculated for the characteristic
mechanical properties of the membrane: membrane's expansivity modulus (kA),
membrane's bending modulus (kc), line tension (Γ) and lysis tension (λc) [20–22].
Sterol content
[mol%]
kA [J/m2] kc [kBT] Γ [×10−11 N] λc [×10−3 N/m] NP [×107]
0 0.213 38.5 2.6 7.8 5.7
30 (ergosterol) 0.241 54.6 2.9 9.5 6.8
30 (cholesterol) 0.354 86.8 3.41 11.9 7.0of a slightly stretched vesicle membrane A, which is determined by
the obtained radius of the tension pore rTP. Using Eq. (7) the hydrostatic
pressure difference can be expressed as
Δp ¼ 2Γ
RvrTP 1þ ΔA=A0ð Þ
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1− r
2
TP
R2v
s
: ð10Þ
The tension pore offers an additional possibility for the passage
of water and sugar molecules through the membrane. Consequently,
a volume ﬂow from the vesicle interior occurs through the tension
pore. For rTP N N d this ﬂow can be described by the equation for a
plane with a circular opening [59]
JTP ¼
Δpr3TP
3η
; ð11Þ
where η is the viscosity of the solution.
The solute ﬂows of sugar molecules through the tension pore are
proportional to the volume ﬂow (JTP). Thus, the corresponding ﬂows
of the sugar molecules through the tension pore are
ΦTP;i ¼
Ni
V
JTP : ð12Þ
4.3.2. Total ﬂow
When the tension pore is formed, the total volume ﬂow is thus
determined using Eqs. (1), (4) and (11)
dV
dt
¼ JNP þ JPB þ JTP ; ð13Þ
whereas the total ﬂow of sugar molecules is determined using Eqs. (2)
and (12)
dNi
dt
¼ ΦNP;i þΦTP;i: ð14Þ
It is assumed that the tension pore closes when the membrane's
elastic energy of the vesicle with an open tension pore (W) is equal to
the membrane's stretching energy of the vesicle with a closed tension
pore. In the model we numerically solve Eqs. (13) and (14) in order to
calculate the time dependence of the tension pore's radius and the
vesicle's volume.
In accordance with the experiments, where the initial sucrose
concentration inside the vesicle and the initial glucose concentration
outside the vesicle were 0.2 mol/l, the corresponding initial number
densities are taken to be 1.2 × 1026/m3. The initial number densities of
the sucrose solution outside and the glucose solution inside the vesicle
are zero. The radius of the vesicle is set to 20 μm and the membrane
thickness to 5 nm. The glucose and sucrose hydrodynamic radii are
taken to be equal to 0.36 nm and 0.46 nm [60], respectively, while the
radius of the nystatin-induced pores is taken to be in the range from
0.4 to 1 nm. The diffusion constants for glucose and sucrose in water
are 6.7 × 10−10 m2/s and 5.2 × 10−10 m2/s, respectively [53,61].
The viscosity of the solutions is taken to be 1 × 10−3 Pas and the
absolute temperature, 297 K. The reﬂection coefﬁcients for the
glucose and sucrose molecules are determined in accordance with
the experimental ﬁndings [62]: the coefﬁcients are equal to 0.2
for Ri /RNP ≤ 0.7 and linearly increase as a function of Ri /RNP
from 0.2 to 1 at 0.7 b Ri /RNP b 1. The permeability coefﬁcient of
the phospholipid bilayer lPB is equal to 4 × 10−13 m3/(Ns) and the hy-
draulic permeability for the nystatin pores (Lp) is estimated with
NP × (πRNP4 /(8ηd)), in accordance with the Hagen-Poisseuille law.
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4.4.1. Different types of tension-pore behavior
Themodel predicts three different vesicle responses in order to com-
pensate for the net ﬂow of water molecules into the vesicle due to the
build-up of a higher concentration of sugarmolecules inside the vesicle,
which occurs as a consequence of the formation of the size-selective
nystatin pores. For a small number of nystatin pores, only a short open-
ing of themembrane occurs. A tension porewhose radius is amaximum
at its occurrence is predicted. Its radius then decreases quickly until the
tension pore closes (type-I tension-pore behavior, Fig. 6a). If the num-
ber of nystatin pores is increased, a long-lasting opening of the mem-
brane is predicted (type-II tension-pore behavior, Fig. 6a). The radius
of this type of tension pore also decreases quickly at the beginning;
however, after a certain value is reached, the tension pore's radius starts
to decrease signiﬁcantly more slowly and the tension pore remains
open for a longer period of time. For the largest numbers of nystatin
pores a further increase in the tension pore's radius, which exceeds its
initial value for the tension pore's occurrence, is theoretically predicted
(type-III tension-pore behavior, Fig. 6a).
In all cases an increase in the volume (and the area) of the vesicle is
predicted until the critical vesicle volume is reached. For low numbers
of nystatin pores the water inﬂow, driven by the osmotic pressure,
induces only a slowly increasing vesicle volume due to the sugar's low
permeability of the nystatin pores. A short opening of the membrane
(type-I tension pore) allows a quick and sufﬁcient outﬂow of water
and sucrose molecules, which is larger than the inﬂow. For the largest
numbers of nystatin pores, in contrast, the occurrence of tension pore
does not provide a sufﬁcient volume outﬂow through the tension
pore. Despite its large initial radius the outﬂow is still lower than the
inﬂow as a result of the high sugar permeability of the nystatin pores
and the volume of the vesicle increases further, above its critical value.Fig. 6. Three characteristic types of tension-pore behavior predicted by the theory for a
0.45-nmnystatin pore radius in sterol-free vesicles. (a) An increase of the tension pore ra-
dius with respect to the initial vesicle radius (rTP/Rv0), which could be assigned to type-I
(dashed line), type-II (full line) and type-III (dash-dot line) tension-pore behavior, respec-
tively. As an example, three different nystatin pore numbers representative for the type-I
(NP = 5 × 106), for the type-II (NP = 3 × 107) and for the type-III (NP = 1 × 108) tension-
pore behavior are depicted. (b) The opening time of the tension pores as a function of the
number of nystatin pores. The ranges of different types of pore behavior (I, II and III) are
also marked.A further increase in the tension pore's radius over its initial value is
needed to compensate for the net ﬂow into the vesicle (type-III
tension-pore behavior). For intermediate numbers of nystatin pores
the sugar permeabilities and, consequently, the water inﬂow are some-
where in themiddle. After the occurrence of tension pore an increase in
the vesicle volume is prevented by the pore that lasts longer, but whose
radius does not exceed its initial value (type-II tension-pore behavior).
A rapid decrease of the tension pore's radius at the beginning is compa-
rable to the type I; however, due to the higher inﬂow the tension pore
cannot close quickly. In other words, the outﬂow through the tension
pore signiﬁcantly decreases with its radius and at a certain tension-
pore radius the water outﬂow through the tension pore equilibrates
the net inﬂow of water, which is higher for intermediate numbers of
nystatin pores. Further changes in the tension-pore radius become
much slower since thewater inﬂowdependsmainly on the sucrose con-
centration inside the vesicle, which slowly decreases.
The number of nystatin pores at which the type-I tension pore
occurs is deﬁned as the number of nystatin pores where at least one
tension pore occurs within 60 minutes. The border between type-I
and type-II tension-pore behavior is deﬁned as the number of nystatin
pores at which the opening time of the tension pore becomes twice as
large and ﬁts approximately to the maximum of the derivative of the
duration of the tension pore's radius with respect to the pore number
(Fig. 6b). It is characterized by the equilibration of the outﬂow through
the tension pore with a net ﬂow of water through themembrane at the
minimum possible tension-pore radius (Section 4.3.2). The border
between type-II and type-III tension-pore behavior is deﬁned as the
minimum number of nystatin pores at which the radius of the tension
pore exceeds its initial value for the occurrence of tension pores. For a
nystatin pore radius equal to 0.45 nm it is estimated that the number
of nystatin pores for which the type-I tension pore occurs is equal to
1600 in a sterol-free membrane. For the transition from type-I to type-
II tension-pore behavior the predicted nystatin pore number is equal
to 1.3 × 107. Furthermore, for the occurrence of the type-III tension-
pore behavior the nystatin pore number should exceed 6.9 × 107.
4.4.2. Inﬂuences of the membrane's mechanical characteristics on the
behavior of the tension pore
The experimentally determined changes in the membrane's
mechanical properties for the sterol-free POPC membrane after the
addition of 30% ergosterol and 30% cholesterol are listed in Table 2.
In order to simulate the inﬂuences of the changed membrane's
expansivity modulus (kA), line tension (Γ) and lysis tension (λc), let
us concentrate on the changes in the number of nystatin pores needed
for the transition from type-II to type-III tension-pore behavior. Using a
0.45-nm nystatin pore radius the model predicts a net increase of
13% for the ergosterol-containing and 11% for cholesterol-containing
membranes in comparison to a sterol-free membrane. The model alsoFig. 7. Three characteristic types of tension-pore behavior as a function of the number and
the radius of the nystatin pores (NP and RNP). Note the minor inﬂuence of the changed
mechanical parameters of the membrane for the sterol-containing membrane with the
addition of 30 mol% ergosterol (dashed line) or 30 mol% cholesterol (dash-dot line) in
comparison with the sterol-free membrane (full line).
Fig. 8. Schematic dependence of the number of nystatin pores on the nystatin concen-
tration in the solution surrounding the vesicle for sterol-free (Δ, full line), 30-mol%
cholesterol- (○, dash-dot line) and for 30-mol% ergosterol-containing membrane
(●, dashed line). The thinner lines denote the sterol-containing membranes before
the modulation due to the changed mechanical characteristics of the membrane.
The thin dotted lines divide the areas where the shape alterations, type-I, type-II
and type-III tension-pore behavior occur.
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if the individual parameter changes are considered. All of them are
higher in the cholesterol-containing membrane than in the ergosterol-
containing membrane.
The effects due to different mechanical characteristics of the
membrane can be presented in amore general case. In Fig. 7 the regions
of different tension-pore behavior are shown in the form of a phase
diagramas a function of the nystatin pore's radius and the pore number.
It can be seen that the same types of tension-pore behavior are mainly
met for a smaller number of nystatin pores if the radius of the pore is in-
creased. Furthermore, the borders between types I and II tension-pore
behavior are shifted in the cholesterol- and ergosterol-containing
membranes towards smaller numbers of nystatin pores. These shifts
are more pronounced in the cholesterol-containing membrane. The
borders between type II and III tension-pore behavior are shifted
towards larger numbers of nystatin pores by comparable values in
both sterol-containing membranes.
4.5. Limitations of the model
It is important to point out some limitations of the model. It is as-
sumed that the glucose and sucrose molecules do not disturb each
other in their passage through the nystatin pore. In addition, it is as-
sumed that the nystatin membrane's incorporation and/or the pore for-
mation do not change themechanical properties of themembrane. For a
vesicle with a radius equal to 20 μm the formation of 1 × 107 nystatin
pores with a radius of 0.45 nm would represent only 0.13 % of the
total vesicle membrane area, which supports the basis of this
assumption. Furthermore, it should be noted that no temporal evolution
of the number and/or the radius of the nystatin pores has been incorpo-
rated into the theoretical model. Nevertheless, our primary goal, i.e., a
basic understanding of the distinct differences in the behavior patterns
of the vesicles, could be achieved.
5. Discussion
Although the discovery and the use of different antibiotics changed
the treatment and the outcome of infections dramatically, the mode of
action of certain antibiotic classes remains to be completely understood.
Studies of the inﬂuence of the polyene nystatin on giant unilamellar
vesicles using phase-contrast microscopy offer a chance to visualize
the membrane effects induced by this antibiotic on the level of individ-
ual vesicles with dimensions that are relevant for an average human
cell. The investigations of sterol-free POPC GUVs revealed a variety of
effects, i.e., vesicle shape changes, the formation of transient tension
pores and the total destruction of the vesicle [43]. Hence, a straightfor-
ward question occurs regarding the inﬂuence of membrane sterols on
the phenomena described.
5.1. Interpretation of the theoretical predictions
A theoreticalmodel based on the theory of osmotic lysis [50] and the
pore-diffusion theory [55] was developed in order to understand the
experimental results (supplementary video material – Appendix B).
Three distinctly different types of tension-pore behavior can be theoret-
ically predicted (Fig. 6a). A close resemblance to the experimentally
observed vesicle behavior patterns, i.e., membrane bursts, slow vesicle
ruptures and explosions (Figs. 1c, 3 and 6), is identiﬁed. Membrane
bursts can be correlated with type-I tension pores (Figs. 1c and 6a).
The observed slow ruptures can be recognized as type-II tension pores
(Figs. 3a and 6a) and vesicle explosions as theoretically predicted
type-III tension pores (Figs. 3b and 6a). For a better match with the
experimental observations, however, it should be kept in mind that
some of the observed slow ruptures do not close as predicted by the
theoretical model, presumably due to the potential instabilities of
open surfaces [63], a process that is not included in our model.Nevertheless, a good correlation between the types of tension
pores predicted by the theoretical model and the experimentally
observed behavior of the vesicles conﬁrms the importance of the
osmotic phenomena and the restricted pore diffusion in the action
of nystatin and similar pore-forming agents on the phospholipid
membrane.
5.2. Effects of ergosterol and cholesterol on the nystatin membrane activity
5.2.1. Basic features
The experimental results show that the succession of the characteris-
tic vesicle behavior patterns, i.e., morphological alterations→ membrane
bursts → slow vesicle ruptures → explosions, are preserved with an
increasing nystatin concentration. In accordance with the literature [32,
33,40], the cholesterol shifts the typical vesicle responses to a minor
extent towards higher nystatin concentrations, while the addition of
ergosterol shifts these responses drastically towards lower nystatin
concentrations, compared to the sterol-free membrane. Most strikingly,
the slow vesicle ruptures start signiﬁcantly sooner, i.e., at 4–5 times
lower nystatin concentrations, in the ergosterol-containing vesicles
(Fig. 5). The early occurrence of slow ruptures in the ergosterol-
containing membranes might play, in addition to the disruption of the
transmembrane electrochemical gradients, an important role in the
medical treatment of fungal diseases with nystatin.
5.2.2. Role of the altered membrane's mechanical characteristics
The addition of cholesterol and ergosterol changes the membrane's
mechanical properties (Table 2); however, the impact of these sterol
speciﬁc inﬂuences on the nystatin activity has not yet been fully quanti-
tatively characterized [17–22]. Based on the presented theoretical
model, amore precise delineation of the role of the changedmechanical
properties of the membrane is obtained. The predictions of the model
show that an increase in the membrane's expansivity modulus (kA)
and the membrane's bending modulus (kc) has the opposite effect to
an increase in the line tension (Γ) and the lysis tension (λc). All these
antagonizing sterol-induced changes to the membrane's mechanical
properties can be compensated for by a maximum change in the
number of nystatin pores of only approximately 30% in the 30-mol%
ergosterol- and cholesterol-containing membranes in order to obtain
the same vesicle response as in the sterol-free membranes. The model
predicts a comparable 13% net compensatory change of nystatin pores
in a 45-mol% cholesterol-containingmembrane. Hence, the small extent
of these changes clearly shows that the signiﬁcantly different behavior
of the ergosterol-containing vesicles cannot be adequately explained
by the changes in the membrane's mechanical characteristics.
2643L. Kristanc et al. / Biochimica et Biophysica Acta 1838 (2014) 2635–26455.2.3. Changes in vesicle behavior due to altered nystatin membrane
binding, partition and aggregation
Since the experimental results cannot be explained on the basis
of the changed mechanical characteristics, the primary focus should
be placed on nystatin binding, partitioning and its aggregation in the
membrane and, consequently, on the formation of the nystatin pores.
A schematic diagram that shows the dependence of the number of
nystatin pores on its concentration in the surrounding medium is pre-
sented in Fig. 8. It is obtained from the correlation of the predictions of
the theoretical model and the experimental observations (Appendix A).
The curves obtained in Fig. 8 clearly demonstrate that the ergosterol
curve is distinctly different from the cholesterol and the sterol-free
curves and can serve as a theoretical illustration of the experimentally
determined distinctions between the responses of the sterol-containing
and sterol-free vesicles. In the ergosterol-containing membranes, a sig-
niﬁcantly quicker formation of nystatin pores is seen at lower nystatin
concentrations (below 100 μmol/l), while a slower increase in the num-
ber of nystatin pores is observed at higher concentrations. In contrast to
this, a slower increase in the number of nystatin pores at lower nystatin
concentrations and a faster increase at higher concentrations are induced
in the cholesterol-containing and the sterol-free membranes (Fig. 8).
This can be associatedwith amore efﬁcient decrease of the halo intensity
and an earlier occurrence of the slow ruptures in the ergosterol-
containing vesicles and, vice versa, a less efﬁcient decrease of the halo
intensity, a shift of the occurrence of slow ruptures to higher nystatin
concentrations and a transition from slow ruptures to explosions at a
smaller nystatin concentration span in the cholesterol-containing and
the sterol-free membranes. The obtained schematic dependencies of
the sterol-free and the sterol-containing GUVs exposed to different
nystatin concentrations are in accordance with the fact that cholesterol
inhibits the effects of nystatin, while ergosterol, despite being only
slightly structurally different, facilitates them [32,33,40]. They also
support the ﬁndings that nystatin can form pores in the sterol-free
membranes [29,42,43] and demonstrate comparable effects in
sterol-free and cholesterol-containing membranes. Furthermore,
our experimental and theoretical results are in accordance with the
signiﬁcantly higher time average conductance [64] as well as higher
% K+ dissipation and the apparent initial rate of the pore formation
[41] reported in the ergosterol-containing vesicles in comparison
with the cholesterol-containing ones. The latter were accompanied
by the changes in the ﬂuorescence lifetime of the nystatin molecules
due to the formation of nystatin-nystatin or nystatin-sterol complexes
in the lipid membranes [41].
5.3. Effects of variations in themembrane ergosterol content on the nystatin
membrane activity
The measurements conﬁrmed that the ergosterol molar fraction is a
very important parameter affecting the nystatin activity in the
ergosterol-POPC membrane. The greatest effects of nystatin, i.e., the
vesicle halo-intensity decrease and the vesicle ruptures, were detected
at 45%, the intermediate at 15% and the lowest ones at 30% ergosterol
membrane molar fraction (Figs. 2, 4 and 5). A 15% change in the
ergosterol membrane molar content is, for example, more important
than a nystatin concentration increase from 25 to 100 μmol at a 30%
ergosterol molar fraction. This molar change induces slow vesicle
ruptures at a 25-μmol/l nystatin concentration for 15% and 45%
ergosterol molar fractions, while they occur for the ﬁrst time at a
100-μmol/l nystatin concentration for a 30% ergosterol molar fraction
(Figs. 2 and 5). The observed effects cannot be explained by the
inﬂuences of ergosterol molar fractions on the basis of the changed
mechanical characteristics of the membrane. The addition of ergosterol
into the membranes results in an increase of the membrane's mechan-
ical parameters nearly in proportion to the increasing ergosterol molar
fraction [20–22]. In addition, themaximal nystatin pore number chang-
es of approximately 20% are predicted by the theoretical model toobtain a comparable tension-pore behavior if the changes in the exper-
imentally determined values for kA, kc, Γ and λc in the POPCmembranes
with 15%, 30% and 45% mol% ergosterol are considered.
Therefore, the sterol-induced changes in the membrane's structural
properties, such as the regularity of the membrane lipid organization,
and their effects on the pore formation process should again be
primarily considered. Our experimental results (Fig. 5) agree on a
qualitative level with the predictions of the superlattice sterol lateral or-
ganization models. These models predict that the nystatin membrane
partition is decreasing in a similar manner: 45 mol% (major local maxi-
mum)→ 15 mol% (minor local maximum)→ 30 mol% (local mini-
mum), in accordance with the extent of the sterol regular
distribution regions [10,24,25].
Alternatively, the POPC-sterol phase diagrams demonstrate a
progressive predominance of a liquid-ordered phase with an in-
creasing sterol membrane content from the liquid-disordered (ld)
over the co-existence of liquid-disordered and liquid-ordered
phase (ld+ lo) to a single liquid-ordered (lo) phase [41]. Thus, a dimin-
ishment of nystatin effects with increasing sterol content is expected if
the ordering of membranes hinders the partition and the formation of
nystatin pores. Nevertheless, our experiments with ergosterol show a
minimal nystatin activity in themiddle of the ld+ lo phase. This implies
that either a more complex membrane behavior of POPC/ergosterol
binary mixture [39] or a more complex dependency of nystatin activity
on the regularity of the membrane's lipid organization exists [65].
6. Conclusions
The effects of ergosterol and cholesterol on the nystatin membrane
activity were studied in GUVs using phase-contrast microscopy.
The experimental results were compared to the characteristic vesicle
behavior observed in the sterol-free vesicles and correlated with the
theoretical model.
The experimental results demonstrated more intense effects in the
ergosterol-containing membranes. Membrane bursts, slow ruptures
and vesicle explosions were detected at signiﬁcantly lower nystatin
concentrations than for the sterol-free and cholesterol-containing
membranes. In addition, an early beginning and a signiﬁcant prolon-
gation of the nystatin concentration span, characterized by the slow
vesicle ruptures, could be observed in the ergosterol-containing
membranes, which might be an important mechanism leading to
cell death in ergosterol-containing fungal cells.
A theoretical model based on restricted pore diffusion and the theory
of osmotic lysis predicts three different types of tension-pore behavior,
depending on the number of nystatin pores. The observed experimental
results can primarily be explained by a signiﬁcantly higher membrane-
binding and pore-formation rate at lower nystatin concentrations in the
ergosterol-containing vesicles in comparison with the cholesterol-
containing and sterol-free vesicles. The role of the changed mechanical
characteristics of the membrane, i.e., the membrane's expansivity modu-
lus, line tension and lysis tension, which could be quantitatively differen-
tiated from the nystatin pore formation activity, was found to be of
secondary importance for the explanation of the observed differences in
the vesicle behavior. In addition, the role of ergosterol membrane molar
fraction was found to be crucial, especially due to its nonlinear effects.
In conclusion, the changes in the phospholipid vesicle behavior in-
duced by different membrane sterol contents were observed and a basic
understanding of this behavior could be achieved. Although amore quan-
titative comparison to the experimental data is still lacking, these results
should be regarded as a step towards a more profound understanding
of the action of polyene antibiotics in biological membranes.
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Appendix A. Correlation between the theoretical predictions and the
experimental observations
The dependence of the number of nystatin pores on its concentra-
tion in the surrounding medium, presented in Fig. 8, is obtained from
the correlation of the following theoretical and experimental results:
i) A sufﬁcient number of nystatin pores for the bursts (type-I
tension pores) that are observed at approximately a 10–20 μmol/l
nystatin concentration in ergosterol-containing membranes
and at approximately 100–200 μmol/l in the cholesterol-
containing and the sterol-free vesicles (Figs. 2 and 4) is
equal to 1.6 × 103, according to the theoretical predictions.
This number of nystatin pores was multiplied by 2, since sig-
niﬁcant halo-intensity changes can be detected experimental-
ly when at least two consecutive bursts occur.
ii) Slow ruptures (type-II tension pores) that are theoretically
predicted above 1.3 × 107 nystatin pores are observed at a
100-μmol/l nystatin concentration in ergosterol-containing
vesicles, which is a signiﬁcantly lower than the 500 μmol/l
and 400 μmol/l in cholesterol-containing and sterol-free
vesicles (Figs. 4 and 5).
iii) The nystatin concentration at which the explosions (type-III
tension pores) become more frequent than the slow ruptures
was found to be, regardless of the membrane composition,
approximately 550 μmol/l (Fig. 5). This implicates roughly
the same theoretically determined number of nystatin pores
(6.9 × 107 nystatin pores) associated with the transition
from type-II to type-III tension-pore behavior. It may seem
to be an oversimpliﬁcation, because in the ergosterol-containing
membranes the transition ismuchmore gradual, but nevertheless,
the pointwhere the explosions prevailmay be determined in spite
of this.
iv) The slope of the halo-intensity decrease is approximately the same
at a 25-μmol/l nystatin concentration in ergosterol-containing
vesicles compared to approximately 200 μmol/l and 220 μmol/l
in the sterol-free and in the cholesterol-containing vesicles,
which also implies the same number of nystatin pores at these
concentrations (Figs. 2 and 4).
v) The halo-intensity decrease in the cholesterol-containing vesicles
is slightly lower at the 400-μmol/l nystatin concentration
compared to that of the sterol-free ones at 300 μmol/l (Fig. 4),
which implies a comparable number of nystatin pores at these
two concentrations.
At the end, the obtained curves for the ergosterol- and cholesterol-
containing vesicles in Fig. 8 were corrected in order to compensate for
the sterol-induced changes of the membrane's mechanical parameters.
Appendix B. Supplementary data
Supplementary video material presenting three distinctly different
types of the observed tension-pore behavior can be found online.
An example of membrane bursts can be found in supplementary
data to Ref. [43]. Supplementary video material to this article con-
tains examples of two types of slow vesicle ruptures. The ﬁrst slow
rupture demonstrates a large membrane opening, which reseals af-
terwards, while the second one represents a more seldom encoun-
tered stable opening with a distinctive oriﬁce leading to a vesicle
disintegration into an amorphous lipid debris. Supplementary
video material to this article also contains an example of a vesicle ex-
plosion. Supplementary data to this article can be found online at
http://dx.doi.org/10.1016/j.bbamem.2014.05.019.References
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